Shanghai Allist Pharmaceuticals Co., Ltd.
688578
Rank in Stocks
#3127
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Share Price
$12.65
Market Cap
$5.69B
Change (1 day)
-0.05%
Change (1 year)
-14.35%
Country
CN
Trade Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Category
Healthcare
P/B ratio for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
P/B ratio as of October 2026 TTM: 4.49
According to Shanghai Allist Pharmaceuticals Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 4.49. At the end of 2024 the company had a P/B ratio of 5.10.
P/B ratio history for Shanghai Allist Pharmaceuticals Co., Ltd. from 2017 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 4.49 | -32.02% |
| 2025 | 6.61 | 29.71% |
| 2024 | 5.10 | 8.19% |
| 2023 | 4.71 | 69.56% |
| 2022 | 2.78 | -40.11% |
| 2021 | 4.64 | 26.86% |
| 2020 | 3.66 | -68.90% |
| 2019 | 11.76 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.251 | 39.11% |
US
|
|
| 13.6307 | 203.34% |
US
|
|
| 4.4521 | -0.92% |
AU
|
|
| 3.2932 | -26.71% |
BE
|
|
| 6.3632 | 41.61% |
NL
|
